Our focus is to treat diseases that cause severe pain and to bring to market non-addictive pain medications. We’re starting with Peripheral Artery Disease (PAD), a painful condition affecting over 8.5 million Americans.
As we work towards Phase 2b trials for our PAD treatment, we have another goal in mind. Treat diseases at the source and reduce the need for opioid prescriptions.
A world without pain is just over the horizon.
So is a new JanOne.
We’re launching our new website soon.